A-Mansia Secures €13M in Funding
A-Mansia Biotech S.A., a Louvain-la-Neuve, Belgium-based microbiome company, secured €13m in funding.
A-Mansia Biotech S.A., a Louvain-la-Neuve, Belgium-based microbiome company, secured €13m in funding.
Dugout, a London, UK-based digital football business, raised £8.275m in funding.
The Stars Group Inc. (NASDAQ: TSG; TSX: TSGI) has agreed to acquire Sky Betting & Gaming, a British-based gambling company featuring UK’s top online casinos reporting a landmark moment in the industry history resulting in the world’s largest publicly listed online gaming company.
8VC, a San Francisco, CA-based venture capital firm, closed its second early-stage fund, at $640m.
Danal, a Costa Mesa, CA-based mobile phone identity and authentication platform, received a strategic investment from Experian.
M31 Italia has sold 100% of Adaptica, an Italian manufacturer of portable devices for the detection and correction of refractive errors and visual defects, to an unnamed eye care group in China.
SHS Gesellschaft für Beteiligungsmanagement (SHS), a Tuebingen, Germany-based independent private equity firm, has started raising capital for its fifth fund.
There is no stopping the gaming industry. International video game revenue in 2015, was estimated at US$91.5 billion; more than double the revenue of the international film industry.
DisperSol Technologies, a Georgetown, Texas-based clinical-stage drug development company, raised $27m in equity financing.
Ndgit, a Munich, Germany-based banking software platform, raised €4m in Series A funding.
Magic AI, a Seattle, WA-based startup focused on horse’s wellness, closed a $1.2M seed funding round.
QuizRR, a Stockholm, Sweden-based edtech company offering innovative training solutions to advance corporate responsibility and worker well-being, raised $1.3m in financing.
VisuWell (formerly known as WeCounsel), a Nashville, Tenn.-based telemedicine enablement company, completed a new round of undisclosed funding.
Kodiak Sciences Inc., a Palo Alto, CA-based development-stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, completed a $33m mezzanine private financing of convertible notes.
Traackr, a San Francisco, Boston, New York, Paris and London-based provider of an influencer relationship management technology platform, raised $9m in Series B funding.